Junko Ikei

Suggest Changes
Learn More
OBJECTIVE This study evaluated the efficacy and safety of Budesonide Inhalation Suspension (BIS) nebulazation by mesh nebulizer in children ages 6 months to 4 years with moderate to severe persistent(More)
  • 1